Twitxy Saved

Brian King

@BrianKingNeo

Neo @BIDMCNeo @Harvardmed. Interests are #neoEBM and health economics. SoMe lead @EBNEO. @AAPNeonatal Journal Club Exec. He/Him. Opinions my own.
Boston, MA Joined August 2018
669 Following 2.6K Followers 8.3K Posts

Latest posts 5

Brian King @BrianKingNeo
If you missed it, the latest @AAPneonatal Journal Club is now up on youtube - youtu.be/8P0-C7d1xJI!

Dr. Budh provided an excellent review of TORPIDO 30/60, with Dr. Ju-Lee Oei and @KapadiaNeo providing great insights. #neotwitter @NeoTECaN @vjain_md @mattie_wolf
www.youtube.com AAP SoNPM Journal Club Webinar - May 28th, 2026 - TORPIDO 30/60 Trial Dr Hetal Budh (Neonatal-Perinatal Fellow, University of Buffalo, NY...
Brian King @BrianKingNeo
After the FDA warning I said that their decision would directly result in excess cases of NEC, and likely mortality.

Several studies since have unfortunately suggested exactly that. Fear of a 1 in 10,000 event resulted in a tangible increase in morbidity, and possibly mortality.
Tolia et al. conducted a natural experiment observational study comparing NEC among infants in high versus low probiotic-use centers to evaluate changes in probiotic use and NEC in preterm infants following the 2023 FDA actions.
buff.ly/mYR4KQW
#EBNeoAlerts #NeoEBM
View quoted post on X
Brian King @BrianKingNeo
Excellent match up.

IMO the cooling trial addressed very common practice creep with no evidence, and (hopefully) put a "moratorium" on the practice for now.

PDA trial added to an already rotund body of evidence, and builds on harms of treatment identified in earlier trials.
The @EBNeo 2025 Impact Article of the Year race is down to the final two!

After a high-stakes first round, these 2 RCTs have emerged as the frontrunners:

Faix et al.
Laughon et al.

Vote now to crown the winner! 🗳️
⏳ Open for 5 days only!
buff.ly/XvU87C4
View quoted post on X